SEC Form 4 · accession 0001209191-15-077529
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Blake
Officer — Vice President, Finance
Period of report
Oct 28, 2015
Accepted (ET)
Oct 30, 2015 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $12.49 | Oct 28, 2015 | A | 7,500 | A | — | Oct 28, 2025 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 28, 2015, such that this option will be fully exercisable on October 28, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.